An endogenous brain neuropeptide with 104 amino acid residues that modulates y-aminobutyric acid receptor function was termed DBI because it displaces diazepam from its specific brain binding sites. Tryptic digestion of DBI generates an octadecaneuropeptide (ODN) that is more potent than the parent compound in the displacement of specifically bound 13-[3H]carboline-3-carboxylate methyl ester ([3H]BCCM) and in proconflict action (Vogel test in thirsty rats). The proconflict action of ODN is antagonized by the imidobenzodiazepinone Ro 15-1788, which is a specific antagonist of fi-carboline and benzodiazepine recognition sites. The ODN amino acid sequence is Gln-Ala-Thr-Val-Gly-Asp-ValAsn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys. The pharmacological properties associated with this sequence were confirmed by comparing the activity of ODN generated from tryptic digestion of DBI with that of ODN obtained by synthesis. Amidation of the terminal lysine of ODN produces a peptide (ODN-NH2) devoid of pharmacological activity. Three peptides containing the COOH-terminal segment of ODN were synthesized. All these peptides [Arg-Pro-Gly-Leu-Leu-AspLeu-Lys (octapeptide), Pro-Gly-Leu-Leu-Asp-Leu-Lys only by 50%. These data suggest that ODN includes a specific ligand for the -aminobutyric acid receptor regulatory site occupied by (3-carbolines. Using rabbit antibodies directed against the NH2-terminal portion of ODN, we detected ODNlike material in rat brain homogenates. However, whether this material is identical to the ODN generated by tryptic digestion of DBI remains to be established.
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Studies on the participation of -y-aminobutyric acid (GABA) in the action of anxiolytic benzodiazepines (BZs) and anxiogenic 3-carboxylate esters of f3-carboline (BC) led to the discovery in rat and human brain of diazepam binding inhibitor (DBI), a naturally occurring neuropeptide that displaces BC and BZ from specific high-affinity recognition sites located in brain synaptic membranes (1) (2) (3) . A partial amino acid sequence ofrat DBI has been obtained (2, 3) . The pharmacological effect of DBI has been tested in primary cultures of mouse spinal cord neurons on GABA-mediated C1-currents recorded in patchclamp conditions (4) and in the Vogel procedure to detect modifications ofrat operant behaviorin conflict situations (2, 3) . In both tests DBI mimicked the action of BC and antagonized the action of BZ. Since BZ/BC recognition sites were shown to be part of the supramolecular organization of postsynaptic GABAA receptors (5) (6) (7) (8) (9) (10) (11) , it was proposed that DBI mightbe the precursor of the physiological effector that allosterically modulates the probability of C1-channel opening elicited by the activation of GABAA receptors. This possibility was supported by the presence in the DBI tryptic digest of an octadecaneuropeptide (ODN) (12) 
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RESULTS
Characterization of DBI Tryptic Fragments. HPLC mapping of peptides generated by tryptic digestion of DBI purified from rat brain revealed seven major tryptic Cr) peptide peaks (Fig. 1) . The amino acid sequences of peptides T4, T5, and T7 were determined and are reported in Fig. 1 . Ofthese peptides only T5, when injected i.c.v. into thirsty rats, elicits a proconflict response similar to that described for DBI (12) . T5 is an octadecapeptide ( Fig. 1 (12) .
Presence of ODN-Like Material in Brain Extracts. To study whether DBI is processed in brain to produce measurable amounts of ODN, an antiserum with high affinity for ODN was prepared (Fig. 2) . Since this antibody has an equal affinity for ODN and ODN-NH2 (see Table 1 for sequence) but also reacts with DBI ( Fig. 2 ) its immunodeterminant appears to reside close to the NH2 terminus of ODN. This inference is supported by the lack of cross-reactivity with 100-fold higher concentrations of various ODN fragments containing five to seven amino acid residues next to the COOH terminus of ODN (see Table 1 for structural details).
Using this antiserum, we detected ODN-like immunoreactivity in acetic acid extracts of rat brain. The ODN-like immunoreactivity eluted from a Bio-Gel P-6 column in two major peaks: a high molecular weight form with an elution profile similar to that of DBI and a smaller molecular weight form that coelutes with ODN (Fig. 3A In vivo behavioral studies. In thirsty rats subjected to a mild electric shock delivered through the drinking tube, ODN injected i.c.v. elicited a dose-related facilitation of the punishment-elicited suppression of drinking. This behavioral (21) . Since the maximal inhibition of drinking behavior reached a base line at approximately V3 of the response obtained in the absence of punishment, the ED30 is close to the dose of peptide that inhibits the behavior by 50%. ED30 is calculated from dose-response curves including at least four different doses of the peptides. (2) . Since the rat response elicited by ODN denotes an exacerbation of conflict, this action is termed proconflict. The EC30 of the proconflict action of ODN (2.9 nmol) is smaller than that of DBI (Table 1 ). This dose of ODN fails to alter unpunished drinking, gross behavior, motor activity, or nociception (measured by the tail-flick technique). The proconflict effect of ODN is prevented by a pretreatment with Ro 15-1788 (Fig. 5) ; in contrast, ODN-NH2 ( Table 1 ). The ED30 doses of OP, HEP, and HEX fail to change unpunished behavior; however, higher doses of these peptides (see Table 1 Since peptide binding studies were plagued by several difficulties, we injected these peptides i.c.v. to determine the involvement of BZ/BC binding sites by measuring the changes elicited in rat operant behavior. The studies show that the conflict action of ODN stems from its interaction with Flu/BC recognition sites because it is antagonized by the immidobenzodiazepinone Ro 15-1788. An important aspect highlighted by the binding and behavioral studies is that the active site of ODN must contain the COOH-terminal sequence. The fragments OP, HEP, and HEX, though weaker than ODN, have a similar but not identical pharmacological profile in the tests we used. OP, HEP, and HEX displace 3H-BCCM and cause proconflict actions similar to ODN and DBI, but, unlike these two latter peptides, they cause convulsions. It will be interesting to raise antibodies against the smaller peptides to establish whether an immunoreactive material similar to OP, HEP, and HEX is detectable in rat brain. An important issue is whether an a-amidating enzyme capable of transforming the a-carboxyl group of the terminal lysine residue of ODN is part of the inactivation process operative in the DBI-ODN family of peptides. Moreover, it remains to be investigated whether DBI is a multifunctional precursor polypeptide capable of generating also a peptide domain that mimics the pharmacological action of the anxiolytic benzodiazepines.
